Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation.

Shin Yeu Ong,Ha Thi Thu Truong,Colin Phipps Diong,Yeh-Ching Linn,Aloysius Yew-Leng Ho,Yeow-Tee Goh,William Ying Khee Hwang

Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation.

2015

Shin Yeu Ong
Ha Thi Thu Truong
Colin Phipps Diong
Yeh-Ching Linn
Aloysius Yew-Leng Ho
Yeow-Tee Goh
William Ying Khee Hwang

Background Valacyclovir has been used for prophylaxis against cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation (HSCT). We investigated the efficacy and safety of high-dose Valacyclovir as pre-emptive therapy in patients with CMV antigenemia after HSCT.

Keywords:

Pathology
Immunology
Hematology
Foscarnet
Hematopoietic stem cell transplantation
Ganciclovir
Virology
Internal medicine
Medicine
conditioning regimen
cmv antigenemia
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations